Online advertising based on Google search terms is a potentially effective way to deliver targeted cancer prevention education, according to a study led by Eleni Linos, MD, DrPH, an assistant professor of dermatology at UC San Francisco.
In an effort to promote skin cancer prevention and detection, the American Academy of Dermatology and the Dallas Cowboys are teaming up to host free SPOTme® skin cancer screenings at Rally Day on Saturday, Oct. 10, from 8 a.m. to 1 p.m.
With one in five Americans developing skin cancer in their lifetime, dermatologists, skin cancer survivors and their families and friends are asking everyone to tell “Skin Cancer, Take a Hike!™” On Saturday, November 7, 2015 at 10 a.m., a 2.5-mile hike will be held at Barton Creek Habitat Preserve, located near Bee Cave Road and Highway 71 in Austin
It is recommended that melanoma patients perform a thorough skin self-exam on a regular basis to look for potential disease recurrence or new melanomas. Research by Rutgers Cancer Institute of New Jersey shows fewer than 15 percent of melanoma patients surveyed regularly examine all parts of their body.
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers and published online today in the New England Journal of Medicine.
As summer draws to a close and children head back to school, many parents are doing everything they can to ensure a healthy school year by scheduling physical exams and making sure vaccinations are up to date. But are parents taking care of themselves? Board-certified dermatologists from the American Academy of Dermatology say that skin cancer – the most common cancer in the United States – can sneak up on anyone, including busy parents.
Breaking a nail is one thing. Breaking a nail-biting habit is another, say member dermatologists from the American Academy of Dermatology. Nail biting typically begins in childhood and can continue through adulthood, and the side effects can be more than cosmetic, say dermatologists.
Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UCSF researchers.
A new nationwide clinical trial comparing two groups of drugs — both effective in treating melanoma.
Click to view today's top stories.
The excitement of a newborn baby turned to worry when a few weeks after Lorenzo Torres-Ramirez was born his parents started to notice red spots on his face.
The American Academy of Dermatology today released new recommendations regarding dermatologic tests and treatments that are not always necessary. This marks the Academy’s second list developed as part of the Choosing Wisely® campaign, an ABIM Foundation initiative designed to help patients avoid care that may be unnecessary for them.
Allergic contact dermatitis is a rash that occurs after the skin comes into contact with an allergen. The substance causing the reaction may be unclear in some cases, but a dermatologist can identify the source of the problem.
According to new research presented at the American Academy of Dermatology’s 2015 Summer Academy Meeting in New York, those with fewer moles may be diagnosed with more aggressive melanoma than those with many moles.
New research, presented at the American Academy of Dermatology’s 2015 Summer Academy Meeting in New York, indicates that psoriasis patients may have an increased risk of depression.
According to new research presented at the American Academy of Dermatology’s 2015 Summer Academy Meeting in New York, some parents are not taking the proper steps to protect their infants from the sun’s harmful ultraviolet rays.
To the untrained eye, all rashes may look alike and seem easily treatable with over-the-counter oral antihistamines or hydrocortisone cream. However, it is not so simple, say member dermatologists from the American Academy of Dermatology.
Organ transplant recipients are twice as likely to develop melanoma as people who do not undergo a transplant, and three times more likely to die of the dangerous skin cancer, suggests new research led by a Johns Hopkins Bloomberg School of Public Health student.
In findings never before seen in melanoma, a novel combination therapy was found to be highly effective at treating patients with skin metastases, new research from UC Davis has shown.
For most the ability to see is often taken for granted. But for the thousands diagnosed with ocular melanoma, the fear of losing their eyesight or even worse, their lives, is an all too real possibility. Ocular melanoma is seen as a rare form of cancer, with approximately two thousand new diagnoses per year. Seattle Cancer Care Alliance Proton Therapy Center has now made proton therapy accessible to patients with localized ocular melanoma.
Results of a phase one trial show that an investigational topical drug, resiquimod gel, causes regression of both treated and untreated tumor lesions and may completely remove cancerous cells from both sites in patients with early stage cutaneous T cell lymphoma (CTCL) – a rare type of non-Hodgkin lymphoma that affects the skin. Currently, there is no cure for CTCL aside from a bone marrow transplant. However, the new study shows that the topical gel can eliminate malignant T cells, leading to diminished lesions.
Moles are benign tumors found on the skin of almost every adult. Scientists have known for years that a mutation in the BRAF gene makes them start growing, but until now haven’t understood why they stop. Now, researchers from the Perelman School of Medicine at the University of Pennsylvania have identified a major genetic factor that keeps moles in their usual non-cancerous, no-growth state.
The American Academy of Dermatology and the Chicago Bears are teaming up to promote skin cancer prevention and detection by hosting free SPOTme® skin cancer screenings on Aug. 6 and 7.
Soldiers who served in the glaring desert sunlight of Iraq and Afghanistan returned home with an increased risk of skin cancer, due not only to the desert climate, but also a lack of sun protection, Vanderbilt dermatologist Jennifer Powers, M.D., reports in a study published recently in the Journal of Investigative Dermatology.
Immune cells that hang around after parasitic skin infection help ward off secondary attack. These skin squatters may prove to be the key to successful anti-parasite vaccines.
Researchers have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner than patients without it. The finding was identified with a genetic mapping technique, genome wide association studies (GWAS), and verified in patient populations from North America and Europe. Published in Nature Communications, this was the first study to survey the entire human genome for genetic variation influencing survival, and is a first step toward applying precision medicine to multiple myeloma.
A Georgetown University Medical Center physician renowned for his research in melanoma will lead a new national clinical trial involving novel treatments for the disease. The study compares the sequencing of two groups of drugs — both effective in treating melanoma.
A UT Southwestern Medical Center dermatologist has improved a technique to transplant pigment cells that can repair the affected area of skin discoloration from vitiligo.
They may look neat, but the dangers of sunburn tattoos far outweigh the coolness factor.
Has your child broken out in an itchy rash? If so, it could be a case of hives. Fortunately, hives are usually harmless and temporary. Common symptoms of hives include slightly raised, pink or red areas on the skin; welts that occur alone, in a group, or connect over a large area; and skin swelling that lessens or goes away within minutes or hours.
As a teen and young adult, Elena Schmidt, 49, visited tanning beds several times a week to maintain her dark skin tone. Mrs. Schmidt, who is of Mexican descent, never wore sunscreen or feared skin cancer.
Chicago-area dermatologists will offer free skin cancer screenings to sun worshipers at the city's most popular beach this summer. The screenings will take place on Saturday, July 18, from 7 am to 5 pm at North Avenue Beach.
New research from the Johns Hopkins Bloomberg School of Public Health suggests that the protein keratin 17 – the presence of which is used in the lab to detect and stage various types of cancers – is not just a biomarker for the disease, but may play a critical role in tumor growth.
Multiple myeloma uses a trick akin to a wolf in sheep’s clothing to grow in and spread to new bone sites. By overexpressing Runx2, a gene that normally is a master regulator of bone formation, the cells of this largely incurable cancer produce proteins that mimic the normal bone-resident cells.
A new study in the Journal of Immunotherapy finds that T cells from patients with melanoma can trigger a protective immune response against the disease.
It’s the season for backyard grilling, campfires, fireworks – and burn injuries. Over the next few months, U.S. burn centers will see thousands of severe burns requiring painful skin grafts and lengthy treatment. Researchers are developing new ways to use already approved therapies to help alleviate the anxiety and pain of burn treatments – as well as improve outcomes.
Monte Shaheen, MD, and colleagues from around the country recently published a paper in the New England Journal of Medicine about a promising new treatment for melanoma.
A rigorous analysis of more than 20,000 medical records concludes that erectile dysfunction drugs, such as Viagra, are not a cause of melanoma, an often deadly form of skin cancer, despite the higher risk for the disease among users of these drugs.
Topics include: women's health, cancer care, research at the Large Hadron Collider, dementia drug treatment, dermatology, skin cancer, breast cancer, smoking risks, and genetics.
Boni Elewski, M.D., and Wendy Cantrell, DNP, pursue research and therapies that bring new drugs to market and change patients’ lives.
The development of targeted therapies has significantly improved the survival of melanoma patients over the last decade; however, patients often relapse because many therapies do not kill all of the tumor cells, and the remaining cells adapt to treatment and become resistant. Moffitt Cancer Center researchers have discovered a novel mechanism that can lead melanoma cells to develop resistance to drugs that target the protein BRAF.
PHOENIX, Ariz. — Mayo Clinic and the Translational Genomics Research Institute (TGen) are helping launch a national clinical trial that will apply the latest in precision medicine to treat advanced melanoma skin cancer.
Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a new study.
As many begin to spend long summer days outside, it’s crucial to have the right information about skin protection and the dangers of sun exposure. Today, Montefiore dermatologist Dr. Holly Kanavy debunks many widely-shared myths regarding skin care and offers accurate information to help people enjoy the outdoors this summer while preserving their skin.
A University of Manchester led trial of a new psoriasis drug has resulted in 40 percent of people showing a complete clearance of psoriatic plaques after 12 weeks of treatment and over 90 percent showing improvement.
Whenever your skin is injured, a scar may form, but there are things you can do at home to help care for these types of minor injuries and reduce the appearance of scars.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right